News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
21
2024
-
11
Linuo Pharmaceutical proudly received approval for the Jinan Expert Workstation, further enhancing its innovative research and development capabilities!
Classification：
News
行业新闻
Corporate News
On November 17, the Jinan Association for Science and Technology held a grand awarding ceremony for the 2024 'Jinan Academician Expert Workstation', jointly applied by Linuo Pharmaceutical and Professor Sun Jianbo, a doctoral supervisor from China Pharmaceutical University.The expert workstation has been successfully approved,marking a new breakthrough for Linuo Pharmaceutical in technological research and development innovation and technology platform upgrades.
The expert workstation is an innovative cooperation model promoted by the China Association for Science and Technology to facilitate industry-university-research collaboration, cultivate innovative talents, and serve enterprise technological innovation.It relies onhigh-level talent experts and their innovative teamsto work together, focusing on joint research and development of new technologies, transformation of scientific and technological achievements, and cultivation of innovative teams.
Since its establishment, Linuo Pharmaceutical has always placed great importance on research and development innovation, collaborating deeply withwell-known domestic and international research institutions and experts,continuously enhancing its research and development capabilities and product competitiveness.
The approval of the Jinan expert workstation will promote the company to further gather high-end intellectual talents, enhance its scientific research innovation capabilities, and improve the technology innovation system that integrates industry, academia, and research.It will further enhance the brand influence of Linuo Pharmaceutical,creating a favorable external environment for the company's development and attracting more outstanding talents, funds, and technological resources.
In the future, Linuo Pharmaceutical will take the cooperation with Professor Sun Jianbo as an opportunity,to continue increasing investment in research and development,deepen industry-university-research cooperation, strengthen talent training and introduction efforts, promote the transformation and application of more scientific research achievements, and contribute more to the progress and development of the health industry.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China